Document is current
Any future updates will be listed below
-
Authors
Xu, Kevin Y. https://orcid.org/0000-0001-6595-695X
Gertner, Alex K.
Greenfield, Shelly F.
Williams, Arthur Robin
Grucza, Richard A.
-
Funding
Funding for this research was provided by:
National Institute on Drug Abuse (R21 DA044744, K12 DA041449)
- License Information
-
More Information
Article History
Received: 9 September 2023
Accepted: 7 March 2024
First Online: 16 March 2024
Declarations
:
: Not applicable.
: Not applicable.
: Dr. Grucza reported receiving grants from the NIH and Arnold Ventures LLC during the conduct of the study, consulting for Janssen Pharmaceuticals, and receiving personal fees for grant reviews from the NIH outside the submitted work. Dr. Williams receives consulting fees, equity, and travel reimbursement from Ophelia Health Inc, a telehealth company for the treatment of OUD. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper.
